AOS Advanced Ophthalmic Systems

July 27, 2023

Every optical business will be using some aspect of AOS technology within the next five years, with the software embedded in diagnostic technology, or within vision-loss monitoring mobile phone apps, says the Surrey-based business.

Founded nine years ago, AOS is leading the drive to bring E-Health to every High Street optical business and hospital eye department, with Founder Karl Jeebaun also chairing the OSA’s E-Health Focus Group. The young business, with a team of 17, was 2022 OPTICIAN Technology Business of the Year.

“The greatest challenge to the UK optical market is the ambiguity surrounding regulations, which correlates directly to the lack of adoption of new technologies. We are addressing this problem and have developed a software platform that enables optometrists and ophthalmologists to provide their patients with hybrid care.

“Our software is designed to take a process which is slow, inefficient and inaccurate to something which is agile, fast and highly accurate.  The key is to manage patients more efficiently and to refine the treatment pathways – that may be in High Street practices. Clinical imaging is a major aspect of our offering and we work with a number of High Street practices, both large and small, to help them to diagnose and manage their patients both in and out of the practice,” said Ben David.

“There is a growing awareness that as a sector, we are probably behind other healthcare specialties and we are addressing this by enhancing the productivity of optical businesses in processing patients through the care pathway,” he added.

The efficiencies of E-Health and managing patients well is bringing significant environmental benefits too –

“We reduced a well know High Street chain’s CO2 emissions by 70,000 kgs last year by facilitating remote monitoring by telehealth. The vast majority of patients like to have online consultations which save them time, inconvenience and travel costs.  The capturing of images and sharing them with the patient certainly aids engagement with the management of their condition too, and is something that we will see more of in the months ahead,” added Ben.